Trials of New Medicines

01.10.14 | By

Those who advocate more aggressive outreach to patients to talk about the potential benefits and importance of clinical research would certainly have felt vindicated during the roll out of "Research in Your Backyard: Pharmaceutical Clinical Trials in Iowa" yesterday in Des Moines.

2014 – A Year of Opportunity

01.10.14 | By

While 2013 was a great year, 2014 promises to be even better. As we look ahead, our focus on facilitating thoughtful discussions on some of the most important health care topics will continue.

Nearly 1,300 Clinical Trials Conducted in the State Since 1999

DES MOINES, IA (January 9, 2014) – Working with Iowa research institutions, including the members of the new Iowa Coalition of Clinical Researchers (ICCR), the nation’s biopharmaceutical research companies have conducted 1,287 clinical trials of new medicines in the state since 1999, according to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA). The total reflects an increase of almost 200 trials in just the last seven months.

Research in Iowa

Using Mobile Technologies to Fight Chronic Disease

01.09.14 | By

Technology is rapidly changing how we conduct even the simplest of daily tasks, and with smartphones, tablets, and other mobile devices, being “connected” is no longer a function of sitting at a desk in front of a computer. We now carry some of the most powerful computers in the palm of our hands, and mobile platforms have opened the door to the creation of some incredibly innovative applications.

Truth is, Science is Expensive

01.09.14 | By

Earlier this week, Scientific American published an excellent blog post by chemist Ashutosh Jogalekar with the cheeky title, “Why drugs are expensive: It’s the science, stupid.” In his well-informed commentary, Jogalekar describes an issue that has faced industry for some time:

Data on Retail Prescription Drug Spending

01.08.14 | By

Looking for the latest data on retail prescription drug spending? We’ve got it here. Yesterday, CMS’ Office of the Actuary released its latest figures on national health care and prescription drug spending for 2012.

Scientific Leadership Advisory Council – Delivering Solutions

01.08.14 | By

This is the third blog post in a series of responses to Luke Timmerman’s Xconomy article, “12 Things the Pharma Industry Can Do to Rebuild Real Public Trust,” in which he says the pharmaceutical industry isn’t doing enough to deliver “big health advances.”

STEM Education

01.07.14 | By

A recent article in Information Week authored by Robert Atkinson, President of the Information Technology and Innovation Foundation, makes an interesting argument about why innovation-focused industries, such as the biopharmaceutical sector, should come together on issues of innovation in order to maintain U.S. competitiveness.

STEM Saves Lives Agenda


Subscribe to RSS - Innovation